ACURA PHARMACEUTICALS INC (ACUR) Financials

ACUR Assets vs Liabilities

DateAssetsLiabilities
2021-12-31 ? ?
2021-09-30 1.4 million 1.3 million
2021-06-30 1.9 million 1.5 million
2021-03-31 1.9 million 8.1 million

ACUR Free Cash Flow and Stock based compensation

No data available :(

ACUR Net Income

No data available :(

ACUR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2021-12-31 - - -
2021-09-30 - - 58000
2021-06-30 - - 66000
2021-03-31 - - -

ACUR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2021-12-31 ?
2021-09-30 65.1 million
2021-06-30 65.1 million
2021-03-31 22.1 million

ACUR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2021-12-31 - - - -
2021-09-30 - 385000 416000 -
2021-06-30 - 390000 523000 -
2021-03-31 - 405000 385000 -

ACUR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2021-12-31 - -
2021-09-30 270000 -
2021-06-30 613000 -
2021-03-31 644000 -

ACUR

Price: $0

52 week price:
0.00
0.05

Earnings Per Share: -0.02 USD

P/E Ratio: -0.10

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 3600

Ebitda: -1.4 million

Market Capitalization: 270607

Links: